Phathom Pharmaceuticals Q3 Revenue Climbs 71.1% to $84.7 Million

Non-GAAP earnings per share were $0.04, beating estimates by $0.01, while revenue missed by $120,000. Phathom reaffirmed its 2026 net revenue outlook of $310 million to $325 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.